Posted on December 4th, 2010 by Health News
(MedPage Today) — A prominent endocrinologist who focuses on preventing heart disease, Robert H. Eckel, MD, of the University of Colorado, talks about the obesity epidemic, the difficulty of reversing population dynamics, and the need for physicians to model the behavior they want their patients to follow with Editor-at-Large George Lundberg, MD, in this segment [...]
No Comments »
Filed under: General Health News
Posted on December 4th, 2010 by Health News
WASHINGTON (MedPage Today) — Congress passed three health-related bills this week and FDA panels weighed in on drugs for thyroid and prostate cancer, a fecal incontinence product, and a weight-loss device.
No Comments »
Filed under: General Health News
Posted on December 4th, 2010 by Health News
(MedPage Today) — GAITHERSBURG, Md. — An FDA advisory committee voted 8-2 that Allergan’s Lap-Band device is safe enough to use in patients with a BMI as low as 30.
No Comments »
Filed under: Pharmacy News
Posted on December 4th, 2010 by Health News
US Oncology, Inc., the nation’s leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US [...]
No Comments »
Filed under: Pharmacy News
Posted on December 4th, 2010 by Health News
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company’s Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with [...]
No Comments »
Filed under: Pharmacy News
Posted on December 4th, 2010 by Health News
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company’s Pleotherapy™ technology platform in patients [...]
No Comments »
Filed under: Pharmacy News
Posted on December 4th, 2010 by Health News
Pfizer Inc. announced today it is planning regulatory submissions of bosutinib in patients with chronic myeloid leukemia (CML) based on data from a clinical program evaluating the compound in newly diagnosed and previously treated patients. These regulatory submissions are planned for 2011.
No Comments »
Filed under: Pharmacy News
Posted on December 4th, 2010 by Health News
Onconova Therapeutics announces its late-stage anticancer agent, Estybon- (ON 01910.Na), will be featured in three presentations at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, FL, December 4-7, 2010.
No Comments »
Filed under: Pharmacy News
Posted on December 4th, 2010 by Health News
Ligand Pharmaceuticals Incorporated today announced that multiple clinical studies of dinaciclib (SCH 727965) will be presented by Merck at the upcoming 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida at the Orange County Convention Center, December 4-7, 2010.
No Comments »
Filed under: Pharmacy News
Posted on December 4th, 2010 by Health News
A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia returns, according to the results of a trial published online in the Lancet today (Saturday).
No Comments »
Filed under: Pharmacy News
